Aguilar Moses Victor Javier 4

What Happened

• Moses Victor Javier Aguilar, Chief Research, Development & Innovation Officer at Procter & Gamble (PG), exercised options for 15,169 shares and immediately sold those 15,169 shares on Feb 13, 2026. The exercise price was $91.07 per share (acquisition cost $1,381,441) and the shares were sold at a weighted average price of $162.28 per share for total proceeds of $2,461,609. The net difference between sale proceeds and exercise cost is about $1,080,168 (pre-tax, before fees).

Key Details

• Transaction date: February 13, 2026.
• Exercise (code M): 15,169 shares acquired at $91.07/share = $1,381,441.
• Sale (code S): 15,169 shares sold at weighted avg $162.28/share = $2,461,609. Price range reported $162.26–$162.311 (see footnote F1 for breakdown).
• Derivative disposition: the exercised derivative was converted/terminated (reported as $0 for derivative disposal).
• Shares owned after the transaction: not specified in the summary information provided.
• Footnotes: F1 = weighted average price; detailed per-share sale prices available on request. F2 = reflects adjustment to PST through Dec 31, 2025.
• Filing: Form 4 filed Feb 17, 2026 (shortly after the Feb 13 transaction).

Context

• This was a common cashless exercise pattern: options were exercised and the resulting shares were immediately sold, which often covers the exercise cost, taxes, or locks in gains. Such sales are routine and do not, by themselves, indicate a change in the insider’s view of the company.